Dedicare AB (publ) Logo

Dedicare AB (publ)

DEDI.ST

(3.5)
Stock Price

70,70 SEK

18.28% ROA

53.16% ROE

9.86x PER

Market Cap.

1.022.534.730,00 SEK

0% DER

5.71% Yield

5.6% NPM

Dedicare AB (publ) Stock Analysis

Dedicare AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dedicare AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (37.27%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

6 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

7 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last three years, showcasing a commitment to providing higher returns.

8 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (2.972), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

9 PBV

The stock's elevated P/BV ratio (3.48x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

10 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

Dedicare AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dedicare AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Dedicare AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dedicare AB (publ) Revenue
Year Revenue Growth
2008 270.608.000
2009 341.796.000 20.83%
2010 331.918.000 -2.98%
2011 408.058.000 18.66%
2012 544.704.000 25.09%
2013 525.421.000 -3.67%
2014 538.599.000 2.45%
2015 573.224.000 6.04%
2016 650.104.000 11.83%
2017 785.230.000 17.21%
2018 812.017.000 3.3%
2019 775.988.000 -4.64%
2020 885.195.000 12.34%
2021 1.249.883.000 29.18%
2022 1.768.008.000 29.31%
2023 2.098.000.000 15.73%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dedicare AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dedicare AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 169.894.000 100%
2017 61.311.000 -177.1%
2018 64.923.000 5.56%
2019 62.245.000 -4.3%
2020 70.194.000 11.32%
2021 97.363.000 27.9%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dedicare AB (publ) EBITDA
Year EBITDA Growth
2008 21.671.000
2009 25.455.000 14.87%
2010 21.067.000 -20.83%
2011 22.207.000 5.13%
2012 32.619.000 31.92%
2013 19.006.000 -71.62%
2014 35.022.000 45.73%
2015 40.078.000 12.62%
2016 70.795.000 43.39%
2017 79.390.000 10.83%
2018 51.435.000 -54.35%
2019 41.950.000 -22.61%
2020 61.385.000 31.66%
2021 102.310.000 40%
2022 154.374.000 33.73%
2023 174.800.000 11.69%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dedicare AB (publ) Gross Profit
Year Gross Profit Growth
2008 91.130.000
2009 110.880.000 17.81%
2010 106.172.000 -4.43%
2011 158.852.000 33.16%
2012 192.001.000 17.27%
2013 159.155.000 -20.64%
2014 167.265.000 4.85%
2015 189.185.000 11.59%
2016 240.594.000 21.37%
2017 139.657.000 -72.27%
2018 116.303.000 -20.08%
2019 103.992.000 -11.84%
2020 125.515.000 17.15%
2021 337.401.000 62.8%
2022 529.416.000 36.27%
2023 364.000.000 -45.44%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dedicare AB (publ) Net Profit
Year Net Profit Growth
2008 15.868.000
2009 18.061.000 12.14%
2010 14.701.000 -22.86%
2011 15.434.000 4.75%
2012 22.420.000 31.16%
2013 13.268.000 -68.98%
2014 28.418.000 53.31%
2015 57.974.000 50.98%
2016 52.938.000 -9.51%
2017 60.078.000 11.88%
2018 38.234.000 -57.13%
2019 26.435.000 -44.63%
2020 36.064.000 26.7%
2021 65.564.000 44.99%
2022 101.297.000 35.28%
2023 116.800.000 13.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dedicare AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 3
2009 4 0%
2010 2 -200%
2011 2 0%
2012 3 50%
2013 1 -100%
2014 3 66.67%
2015 6 50%
2016 6 -20%
2017 7 16.67%
2018 4 -50%
2019 3 -100%
2020 4 33.33%
2021 7 50%
2022 11 40%
2023 12 16.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dedicare AB (publ) Free Cashflow
Year Free Cashflow Growth
2008 17.235.000
2009 1.311.000 -1214.65%
2010 349.000 -275.64%
2011 29.883.000 98.83%
2012 31.648.000 5.58%
2013 -5.900.000 636.41%
2014 40.491.000 114.57%
2015 12.509.000 -223.69%
2016 34.551.000 63.8%
2017 81.837.000 57.78%
2018 14.059.000 -482.1%
2019 45.219.000 68.91%
2020 37.538.000 -20.46%
2021 67.299.000 44.22%
2022 99.974.000 32.68%
2023 37.800.000 -164.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dedicare AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2008 17.449.000
2009 1.829.000 -854.02%
2010 505.000 -262.18%
2011 30.287.000 98.33%
2012 32.643.000 7.22%
2013 -5.059.000 745.25%
2014 41.715.000 112.13%
2015 14.896.000 -180.04%
2016 35.172.000 57.65%
2017 82.165.000 57.19%
2018 18.656.000 -340.42%
2019 46.954.000 60.27%
2020 40.105.000 -17.08%
2021 69.587.000 42.37%
2022 105.337.000 33.94%
2023 38.300.000 -175.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dedicare AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2008 214.000
2009 518.000 58.69%
2010 156.000 -232.05%
2011 404.000 61.39%
2012 995.000 59.4%
2013 841.000 -18.31%
2014 1.224.000 31.29%
2015 2.387.000 48.72%
2016 621.000 -284.38%
2017 328.000 -89.33%
2018 4.597.000 92.86%
2019 1.735.000 -164.96%
2020 2.567.000 32.41%
2021 2.288.000 -12.19%
2022 5.363.000 57.34%
2023 500.000 -972.6%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dedicare AB (publ) Equity
Year Equity Growth
2008 28.112.000
2009 48.681.000 42.25%
2010 61.861.000 21.31%
2011 36.532.000 -69.33%
2012 51.396.000 28.92%
2013 48.104.000 -6.84%
2014 66.088.000 27.21%
2015 101.742.000 35.04%
2016 121.691.000 16.39%
2017 109.460.000 -11.17%
2018 102.455.000 -6.84%
2019 93.088.000 -10.06%
2020 135.423.000 31.26%
2021 178.493.000 24.13%
2022 262.557.000 32.02%
2023 285.400.000 8%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dedicare AB (publ) Assets
Year Assets Growth
2008 84.934.000
2009 97.130.000 12.56%
2010 113.732.000 14.6%
2011 117.117.000 2.89%
2012 141.745.000 17.37%
2013 130.125.000 -8.93%
2014 159.740.000 18.54%
2015 189.910.000 15.89%
2016 232.282.000 18.24%
2017 233.030.000 0.32%
2018 215.819.000 -7.97%
2019 239.169.000 9.76%
2020 384.608.000 37.81%
2021 497.861.000 22.75%
2022 742.684.000 32.96%
2023 727.000.000 -2.16%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dedicare AB (publ) Liabilities
Year Liabilities Growth
2008 56.822.000
2009 48.449.000 -17.28%
2010 51.871.000 6.6%
2011 80.585.000 35.63%
2012 90.349.000 10.81%
2013 82.021.000 -10.15%
2014 93.652.000 12.42%
2015 88.168.000 -6.22%
2016 110.591.000 20.28%
2017 123.570.000 10.5%
2018 113.364.000 -9%
2019 146.081.000 22.4%
2020 249.185.000 41.38%
2021 319.368.000 21.98%
2022 480.127.000 33.48%
2023 441.600.000 -8.72%

Dedicare AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
209.77
Net Income per Share
10.65
Price to Earning Ratio
9.86x
Price To Sales Ratio
0.51x
POCF Ratio
5.85
PFCF Ratio
6.13
Price to Book Ratio
3.52
EV to Sales
0.44
EV Over EBITDA
5.32
EV to Operating CashFlow
5.12
EV to FreeCashFlow
5.26
Earnings Yield
0.1
FreeCashFlow Yield
0.16
Market Cap
1,02 Bil.
Enterprise Value
0,88 Bil.
Graham Number
84.55
Graham NetNet
-31.02

Income Statement Metrics

Net Income per Share
10.65
Income Quality
3.45
ROE
0.37
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.79
EBT Per Ebit
0.24
Ebit per Revenue
0.29
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.37
Operating Profit Margin
0.29
Pretax Profit Margin
0.07
Net Profit Margin
0.06

Dividends

Dividend Yield
0.06
Dividend Yield %
5.71
Payout Ratio
0.56
Dividend Per Share
6

Operating Metrics

Operating Cashflow per Share
17.94
Free CashFlow per Share
17.44
Capex to Operating CashFlow
-0.03
Capex to Revenue
-0
Capex to Depreciation
-0.37
Return on Invested Capital
0.39
Return on Tangible Assets
0.18
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0.5

Balance Sheet

Cash per Share
15,16
Book Value per Share
29,85
Tangible Book Value per Share
12.06
Shareholders Equity per Share
29.85
Interest Debt per Share
1.15
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-0.88
Current Ratio
1.44
Tangible Asset Value
0,12 Bil.
Net Current Asset Value
0,07 Bil.
Invested Capital
0
Working Capital
0,16 Bil.
Intangibles to Total Assets
0.23
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dedicare AB (publ) Dividends
Year Dividends Growth
2012 1
2013 1 0%
2014 1 0%
2015 2 50%
2016 2 0%
2017 4 33.33%
2018 5 40%
2019 4 -25%
2020 3 -100%
2021 3 0%
2022 4 50%
2023 6 33.33%

Dedicare AB (publ) Profile

About Dedicare AB (publ)

Dedicare AB (publ) operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. The company hires and recruits doctors, nurses, social workers, and managers, as well as other staff in health and social work. It provides individual temporary staffing, as well as department, unit, or operations team staffing services. The company was founded in 1996 and is headquartered in Stockholm, Sweden.

CEO
Mr. Krister Widstrom
Employee
1.079
Address
Ringvägen 100
Stockholm, 118 60

Dedicare AB (publ) Executives & BODs

Dedicare AB (publ) Executives & BODs
# Name Age
1 Mr. Kasper Madsen
Adm. Manager and MD & Chief Executive Officer of Denmark
70
2 Ms. Jenny Pizzignacco
Head of HR & Director
70
3 Mr. Krister Widstrom
Chief Executive Officer & MD
70
4 Ms. Anette Sandsjo
Chief Financial Officer
70
5 Mr. Mattis Kjellin
Chief Information Officer
70
6 Mr. Bard Kristiansen
Chief Executive Officer & MD of Norway
70
7 Ms. Eva Brunnberg
MD & Chief Executive Officer of Sweden
70

Dedicare AB (publ) Competitors

Betsson AB Logo
Betsson AB

BETS-B.ST

(3.8)
Björn Borg AB (publ) Logo
Björn Borg AB (publ)

BORG.ST

(2.0)
Novotek AB Logo
Novotek AB

NTEK-B.ST

(2.8)
CellaVision AB (publ) Logo
CellaVision AB (publ)

CEVI.ST

(3.5)
Mycronic AB (publ) Logo
Mycronic AB (publ)

MYCR.ST

(2.8)